Arthur F. Ryan
At a glance: Arthur F. Ryan is Director at Regeneron Pharmaceuticals (REGN). Their latest SEC Form 4, filed Jul 7, 2026, reported a sale of $130K. On file: 0 purchase lines ($0) and 48 sale lines ($435K).
Disclosed holdings: about $16.1M of REGN stock: 17,303 shares reported on their latest Form 4 (filed Jul 7, 2026), valued at the Nov 19, 2026 close of $932.53. This counts only REGN shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Arthur F. Ryan's InsiderPrint
48 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
Reading this print: Almost only sells, trading about 48 times a year, typically $4K a trade; most sales are on a pre-planned 10b5-1 schedule.
- Bump outward: a purchase (0)
- Dent inward: a sale (48)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Insiders with a similar print
- Mark A. Welsh IIIDirector · NOC · 100% match
- Kevin RubinCFO · ZS · 99% match
- Eynav AzariaSee Remarks · KLTR · 99% match
- Randall MoreadithChief Scientific Officer · SER · 99% match
- Francis LaurencioCFO · ATOM · 99% match
Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 7SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 20017,303 held (−1%) | $650.15 | $130K | +43.4% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 517,598 held (−0%) | $701.76 | $4K | +32.9% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1517,583 held (−0%) | $702.46 | $11K | +32.8% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2417,559 held (−0%) | $703.46 | $17K | +32.6% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1517,544 held (−0%) | $704.28 | $11K | +32.4% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1417,530 held (−0%) | $705.56 | $10K | +32.2% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 717,523 held (−0%) | $706.74 | $5K | +31.9% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 417,519 held (−0%) | $707.40 | $3K | +31.8% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 617,513 held (−0%) | $709.45 | $4K | +31.4% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 217,511 held (−0%) | $710.87 | $1K | +31.2% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 517,506 held (−0%) | $711.49 | $4K | +31.1% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 117,505 held (−0%) | $712.09 | $712 | +31.0% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 217,503 held (−0%) | $714.13 | $1K | +30.6% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 117,702 held (−0%) | $771.32 | $771 | +20.9% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 317,699 held (−0%) | $772.76 | $2K | +20.7% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 817,691 held (−0%) | $773.59 | $6K | +20.5% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 817,683 held (−0%) | $774.58 | $6K | +20.4% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1417,669 held (−0%) | $775.58 | $11K | +20.2% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1317,656 held (−0%) | $776.62 | $10K | +20.1% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 917,647 held (−0%) | $777.42 | $7K | +20.0% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 417,643 held (−0%) | $778.24 | $3K | +19.8% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4017,603 held (−0%) | $779.71 | $31K | +19.6% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 717,796 held (−0%) | $777.46 | $5K | +19.9% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 217,794 held (−0%) | $778.30 | $2K | +19.8% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 517,789 held (−0%) | $779.69 | $4K | +19.6% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 317,786 held (−0%) | $780.69 | $2K | +19.5% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 217,784 held (−0%) | $781.21 | $2K | +19.4% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 217,782 held (−0%) | $782.62 | $2K | +19.2% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1017,772 held (−0%) | $783.62 | $8K | +19.0% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 917,763 held (−0%) | $784.48 | $7K | +18.9% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1117,752 held (−0%) | $785.48 | $9K | +18.7% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 717,745 held (−0%) | $786.61 | $6K | +18.6% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 217,743 held (−0%) | $787.34 | $2K | +18.4% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2017,723 held (−0%) | $788.96 | $16K | +18.2% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2017,703 held (−0%) | $789.28 | $16K | +18.2% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 117,902 held (−0%) | $775.63 | $776 | +20.2% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1017,892 held (−0%) | $776.59 | $8K | +20.1% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5717,835 held (−0%) | $777.56 | $44K | +19.9% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1217,823 held (−0%) | $778.53 | $9K | +19.8% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 517,818 held (−0%) | $779.41 | $4K | +19.6% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 117,817 held (−0%) | $780.09 | $780 | +19.5% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 517,812 held (−0%) | $781.48 | $4K | +19.3% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 117,811 held (−0%) | $782.53 | $783 | +19.2% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 317,808 held (−0%) | $783.34 | $2K | +19.0% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 117,807 held (−0%) | $784.59 | $785 | +18.9% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 117,806 held (−0%) | $785.71 | $786 | +18.7% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 217,804 held (−0%) | $786.29 | $2K | +18.6% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 117,803 held (−0%) | $787.82 | $788 | +18.4% |
- Sell
Director Arthur F Ryan sold $130K of REGN at $650.15 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $4K of REGN at $701.76 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $11K of REGN at $702.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $17K of REGN at $703.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $11K of REGN at $704.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $10K of REGN at $705.56 — pre-scheduled 10b5-1 plan sale.
Follow Arthur F. Ryan
Get one email when Arthur F. Ryan files a new purchase or sale. Free.
At most one email a day about Arthur F. Ryan, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.